Interleukin-22 acts as a mitochondrial protector

descriptionPublicationkeyboard_double_arrow_right Article , Other literature type 01 Jan 2020 English Publisher:Ivyspring International PublisherJournal:Theranostics, volume 10, pages 7,836-7,840 (issn: 1838-7640,

Copyright policy )

Authors: Hwang, Seonghwan; Feng, Dechun; Gao, Bin;

doi: 10.7150/thno.48022

pmid: 32685023

pmc: PMC7359092

Interleukin-22 acts as a mitochondrial protector

- Summary
- Subjects
- Metrics

Abstract

Interleukin (IL)-22 has been increasingly recognized as a promising therapeutic option for various types of diseases. This commentary summarizes the novel mechanistic aspects of IL-22 for the treatment of liver diseases including the study by Chen et al. published in the recent issue of the Theranostics that elucidated the novel function of IL-22 as a mitochondrial protector for the adaptive defense against liver injury.

Related Organizations

National Institutes of Health
United States
National Institute of Health
Pakistan
National Institute of Health (NIH/NICHD)
United States
National Institute On Alcohol Abuse and Alcoholism
United States

Keywords

Editorial, Interleukins, Liver Diseases, Humans, Interleukin-22, Mitochondria

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	7
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%